Cover Image
市場調查報告書

顱顏面固定 (CMF):開發中產品分析

Cranio Maxillofacial Fixation (CMF) - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 333504
出版日期 內容資訊 英文 64 Pages
訂單完成後即時交付
價格
Back to Top
顱顏面固定 (CMF):開發中產品分析 Cranio Maxillofacial Fixation (CMF) - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年04月01日 內容資訊: 英文 64 Pages
簡介

在本報告提供全球各國的企業·醫療機關等正在開發的顱顏面固定 (以下CMF) 相關設備的開發中產品資訊相關分析,臨床實驗/產品開發的整體進展,及各階段·各地區·各領域的詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),近來的產品開發·資本交易的動向等資料為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 顱顏面固定 (CMF) 概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:法規各途徑
  • 開發中產品:認證各時期 (估計)

第4章 CMF:正在開發的開發中產品 (各企業)

  • CMF的開發企業:各開發階段的開發中產品
  • CMF:各開發階段的開發中產品

第5章 CMF的開發企業·產品概要

  • Advanced BioMedical Technologies, Inc.:企業概要
    • 開發中產品及進行中的臨床實驗概要
  • Clemson University:企業概要
  • Histocell S.L.:企業概要
  • IlluminOss Medical, Inc.:企業概要
  • OsteoVantage, Inc.:企業概要
  • Renishaw plc:企業概要
  • University of South Florida:企業概要

第6章 CMF:近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0319EPD

GlobalData's Medical Devices sector report, "Cranio Maxillofacial Fixation (CMF) - Medical Devices Pipeline Assessment, 2017" provides an overview of Cranio Maxillofacial Fixation (CMF) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Cranio Maxillofacial Fixation (CMF) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cranio Maxillofacial Fixation (CMF) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cranio Maxillofacial Fixation (CMF) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cranio Maxillofacial Fixation (CMF) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Cranio Maxillofacial Fixation (CMF) Overview 5

3 Products under Development 6

  • 3.1 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Stage of Development 6
  • 3.2 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Segment 7
  • 3.3 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Territory 8
  • 3.4 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Regulatory Path 9
  • 3.5 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Estimated Approval Date 10

4 Cranio Maxillofacial Fixation (CMF) - Pipeline Products under Development by Companies 11

  • 4.1 Cranio Maxillofacial Fixation (CMF) Companies - Pipeline Products by Stage of Development 11
  • 4.2 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Stage of Development 12

5 Cranio Maxillofacial Fixation (CMF) Companies and Product Overview 13

  • 5.1 Advanced BioMedical Technologies, Inc. Company Overview 13
    • 5.1.1 Advanced BioMedical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.2 Biologitech Srl Company Overview 15
    • 5.2.1 Biologitech Srl Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.3 Clemson University Company Overview 16
    • 5.3.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.4 Histocell SL Company Overview 17
    • 5.4.1 Histocell SL Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.5 IlluminOss Medical, Inc. Company Overview 18
    • 5.5.1 IlluminOss Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.6 OssDsign AB Company Overview 20
    • 5.6.1 OssDsign AB Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.7 OsteoVantage Inc Company Overview 22
    • 5.7.1 OsteoVantage Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.8 Renishaw Plc Company Overview 23
    • 5.8.1 Renishaw Plc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.9 University of South Florida Company Overview 24
    • 5.9.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.10 Xtant Medical Holdings Inc Company Overview 25
    • 5.10.1 Xtant Medical Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 25

6 Cranio Maxillofacial Fixation (CMF)- Recent Developments 26

  • 6.1 Mar 23, 2017: SpineGuard Reports Full-Year 2016 Financial Results 26
  • 6.2 Mar 14, 2017: LISI Medical Remmele Planning Big Lake Expansion 27
  • 6.3 Mar 13, 2017: Oxford Performance Materials: European Patent Granted for OsteoFab Implants 28
  • 6.4 Mar 09, 2017: Xtant Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period 28
  • 6.5 Mar 09, 2017: Cantel Medical Reports Financial Results For The Second Quarter Ended January 31, 2017 30
  • 6.6 Feb 23, 2017: Renishaw exhibiting at BioWales 2017 31
  • 6.7 Feb 22, 2017: Xtant Medical Announces Appointment of Carl O'Connell to Permanent CEO 31
  • 6.8 Feb 02, 2017: Karolinska Development portfolio company OssDsign announces agreement for distribution of OSSDSIGN Cranial in the USA with Matador Medical 32
  • 6.9 Feb 02, 2017: OssDsign Enters into Agreement with Matador Medical 33
  • 6.10 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 33
  • 6.11 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 34
  • 6.12 Jan 23, 2017: Xtant Medical CEO Dan Goldberger announces resignation 36
  • 6.13 Jan 20, 2017: OssDsign Announces FDA 510(k) Clearance of OSSDSIGN Cranial for Sale in the USA 36
  • 6.14 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 37
  • 6.15 Jan 12, 2017: OssDsign Enters into Agreement for its Products Distribution 37
  • 6.16 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 37
  • 6.17 Jan 11, 2017: XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA 38
  • 6.18 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 38
  • 6.19 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 40
  • 6.20 Jan 03, 2017: Cantel Medical Appoints Dottie Donnelly Brienza as Senior Vice President and Chief Human Resources Officer 40
  • 6.21 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 41
  • 6.22 Dec 08, 2016: Cantel Medical Reports Record Results For The First Quarter Ended October 31, 2016 41
  • 6.23 Nov 07, 2016: Xtant Medical Holdings Reports Record Third Quarter 2016 Results 42
  • 6.24 Nov 01, 2016: Xtant Medical Receives Approval of Compliance Plan from NYSE MKT 43
  • 6.25 Oct 31, 2016: Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 44
  • 6.26 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 44
  • 6.27 Oct 27, 2016: Stryker reports third quarter 2016 results 45
  • 6.28 Oct 11, 2016: Xtant Medical Pre-Announces Record Third Quarter 2016 Revenue 46
  • 6.29 Oct 06, 2016: Xtant Medical Announces the Appointment of Carl O'Connell as President 47
  • 6.30 Sep 29, 2016: Cantel Medical Reports Record Results for the Fourth Quarter Ended July 31, 2016 47
  • 6.31 Sep 14, 2016: SpineGuard Reports Six-Month 2016 Financial Results 48
  • 6.32 Sep 04, 2016: Cranioplasty using OSSDSIGN Cranial - preliminary data from a retrospective study 49
  • 6.33 Sep 01, 2016: Cantel Medical Promotes Seth M. Yellin to Executive Vice President 50
  • 6.34 Aug 19, 2016: Xtant Medical Receives Non Compliance Notice from NYSE MKT 50
  • 6.35 Aug 16, 2016: Xtant Medical Expands AR Credit Facility with Silicon Valley Bank 50
  • 6.36 Aug 01, 2016: Xtant Medical Reports Second Quarter 2016 Results 51
  • 6.37 Aug 01, 2016: Cantel Medical Names Jorgen B. Hansen as New President and CEO 52
  • 6.38 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results 52
  • 6.39 Jul 26, 2016: Xtant Medical Announces the Operations Expansion of Montana's Tissue Processing Rooms 53
  • 6.40 Jul 21, 2016: Stryker reports second quarter 2016 results 54
  • 6.41 Jul 20, 2016: Xtant Medical Pre-Announces Second Quarter 2016 Revenue and EBITDA 55
  • 6.42 Jul 19, 2016: DePuy Synthes Announces Agreement with Materialise for 3D-Printed Titanium Cranio-Facial Implants 55
  • 6.43 Jul 19, 2016: Materialise Enters into Distribution Agreement with DePuy Synthes 56
  • 6.44 Jul 12, 2016: SpineGuard Reports 29% Growth and €1.9M Revenue for the Second Quarter 2016 56
  • 6.45 Jun 17, 2016: Cantel Medical Announces Appointment of Dr. Ronnie Myers to its Board of Directors 57
  • 6.46 Jun 16, 2016: Xtant Medical Announces Changes to Its Executive Management and Board of Directors 57
  • 6.47 Jun 13, 2016: Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 58
  • 6.48 Jun 08, 2016: Cantel Medical Announces Record Financial Results for Third Quarter 2016 58
  • 6.49 Jun 07, 2016: Zimmer Biomet Raises USD532 Million in Public Offering of 2.42% Notes Due 2026 59
  • 6.50 Jun 07, 2016: Zimmer Biomet Raises USD532 Million in Public Offering of 1.4% Notes Due 2022 60
  • 6.51 May 26, 2016: Xtant Medical completes new accounts receivable revolver credit facility with Silicon Valley Bank 60
  • 6.52 May 02, 2016: Xtant Medical Raises USD65 Million in Private Placement of Notes 60

7 Appendix 61

  • 7.1 Methodology 61
  • 7.2 About GlobalData 64
  • 7.3 Contact Us 64
  • 7.4 Disclaimer 64

List of Tables

1.1 List of Tables

  • Table 1: Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Stage of Development 6
  • Table 2: Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Segment 7
  • Table 3: Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Territory 8
  • Table 4: Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Regulatory Path 9
  • Table 5: Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Estimated Approval Date 10
  • Table 6: Cranio Maxillofacial Fixation (CMF) Companies - Pipeline Products by Stage of Development 11
  • Table 7: Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Stage of Development 12
  • Table 8: Advanced BioMedical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 13
  • Table 9: Bioabsorbable Miniscrew - Product Status 13
  • Table 10: Bioabsorbable Miniscrew - Product Description 13
  • Table 11: Polyamide Biodegradable Plate - Product Status 14
  • Table 12: Polyamide Biodegradable Plate - Product Description 14
  • Table 13: Biologitech Srl Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 14: Surgiplanner - Product Status 15
  • Table 15: Surgiplanner - Product Description 15
  • Table 16: Clemson University Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 17: Velox - Product Status 16
  • Table 18: Velox - Product Description 16
  • Table 19: Histocell SL Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 20: Maxillofacial Implant - Product Status 17
  • Table 21: Maxillofacial Implant - Product Description 17
  • Table 22: IlluminOss Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 23: Photodynamic Bone Stabilization System - Cranio-maxillofacial - Product Status 18
  • Table 24: Photodynamic Bone Stabilization System - Cranio-maxillofacial - Product Description 19
  • Table 25: OssDsign AB Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 26: OSSDSIGN Cranial PSI - Product Status 20
  • Table 27: OSSDSIGN Cranial PSI - Product Description 20
  • Table 28: OSSDSIGN Facial PSI - Product Status 21
  • Table 29: OSSDSIGN Facial PSI - Product Description 21
  • Table 30: OsteoVantage Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 31: Electroconductive Mesh - Product Status 22
  • Table 32: Electroconductive Mesh - Product Description 22
  • Table 33: Renishaw Plc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 34: Facial Implant - Product Status 23
  • Table 35: Facial Implant - Product Description 23
  • Table 36: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 37: Custom Reduction Splint - Product Status 24
  • Table 38: Custom Reduction Splint - Product Description 24
  • Table 39: Xtant Medical Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 40: Anti-Microbial Coated GenerOs CF - Product Status 25
  • Table 41: Anti-Microbial Coated GenerOs CF - Product Description 25
  • Table 42: Glossary 63

List of Figures

1.2 List of Figures

  • Figure 1: Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Stage of Development 6
  • Figure 2: Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Segment 7
  • Figure 3: Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Territory 8
  • Figure 4: Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Regulatory Path 9
  • Figure 5: Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Estimated Approval Date 10
Back to Top